Short-Term Treatment with Metformin Improves the Cardiovascular Risk Profile in First-Degree Relatives of Subjects with Type 2 Diabetes Mellitus who have a Metabolic Syndrome and Normal Glucose Tolerance without Changes in C-Reactive Protein or Fibrinogen

OBJECTIVE: To study if metformin, when administered to first-degree relatives of type 2 diabetes mellitus subjects who have metabolic syndrome and normal glucose tolerance, could improve the cardiovascular risk profile and reduce the levels of both C-reactive protein and fibrinogen. INTRODUCTION: Me...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lima, Luis Mauro Alvim, Wiernsperger, Nicolas, Kraemer-Aguiar, Luiz Guilherme, Bouskela, Eliete
Formato: Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2009
Materias:
Clinical Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694245/
https://www.ncbi.nlm.nih.gov/pubmed/19488607
http://dx.doi.org/10.1590/S1807-59322009000500008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694245/
https://www.ncbi.nlm.nih.gov/pubmed/19488607
http://dx.doi.org/10.1590/S1807-59322009000500008

Ejemplares similares